Use of Methylphenidate in Children and Adolescents
Conditions
Keywords
methylphenidate, drug utilisation study, pediatrics
Brief summary
The use of methylphenidate in children and adolescents in France from 2010 to 2015
Detailed description
To describe the use of methylphenidate in children and adolescents in France from 2010 to 2015
Interventions
OTHERusers of methylphenidate
Children and adolescents who are users of methylphenidate, 2010 to 2015
Sponsors
Assistance Publique - Hôpitaux de Paris
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
No minimum to 17 Years
Healthy volunteers
No
Inclusion criteria
* children and adolescents (0-17 years) * registered in the French Health Insurance Database from 2012-2015
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| use of methylphenidate over time | 6 years | Describe of the use of methylphenidate over time to determine the impact of regulatory information of appropriate prescription conditions of use in September 2012 |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Describe methylphenidate patterns of use over time | 6 years | Pharmaceutical specialties (immediate or extended release forms) prescribed by type of delivery: initial or renewals. Profile of prescribers: hospital or private practice (general practitioners, specialists) depending on type of prescription (initial or renewal); geographical distribution of the prescribers Profile of patients: sex, average age and age classes (0-23 months, 2-5 years, 6-11 years, 12-17 years), socioeconomic status, long-lasting diseases status for psychosis, severe personality disorder, mental retardation. Pattern of methylphenidate use: duration of treatment, prolonged use, interruption of treatment. |
| Co-prescription of methylphenidate and non-psychostimulant psychotropic drugs | 6 years | — |
Countries
France
Outcome results
None listed